The Clorox Company — Wall Street Analyst Estimates & Price Targets

CLX

NYSEConsumer DefensiveHousehold & Personal ProductsCIK 0000021076thecloroxcompany.comAbout CLX

Last close · Oct 16, 202687.09+0.89 (+1.03%)

Market cap$10.5B

6 firms' latest targets, last 90 days: median $94.50 ($80.00–$99.00), 9% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker

Each firm's latest target

last 90 days · 6 firms

Date	Firm	Target	Previous	Change	Vs price then	Vs price now
2026-10-16	Barclays	$80.00	$84.00	▼ 5%	-7%	-8%
2026-10-15	UBS	$91.00	$105.00	▼ 13%	+5%	+4%
2026-10-15	Morgan Stanley	$87.00	$97.00	▼ 10%	+0%	+0%
2026-08-04	Deutsche Bank	$98.00	$94.00	▲ 4%	-3%	+13%
2026-08-04	Evercore ISI	$99.00	$98.00	▲ 1%	-2%	+14%
2026-07-28	Jefferies	$98.00	$139.00	▼ 29%	+1%	+13%

Consensus estimates

revenue and EPS by fiscal year · reported years marked

FY	Revenue	YoY	EPS	YoY	Revenue range	EPS range	Analysts
2023reported	$7.4B	+4%	$1.20	-68%	est. $7.2B+2%	est. $4.59	9
2024reported	$7.1B	-4%	$2.25	+88%	est. $7.5B-5%	est. $2.88	9
2025reported	$7.1B	+0%	$6.52	+190%	est. $7.0B+1%	est. $7.04	10
2026	$6.7B	-6%	$5.52	-22%	$6.7B–$6.7B	$5.48–$5.59	10
2027	$7.6B	+14%	$5.74	+4%	$7.6B–$7.7B	$5.52–$5.81	12
2028	$7.8B	+2%	$6.19	+8%	$7.7B–$7.9B	$6.06–$6.34	12
2029	$8.0B	+3%	$6.48	+5%	$7.8B–$8.1B	$5.91–$7.36	9
2030	$8.3B	+4%	$6.94	+7%	$8.2B–$8.4B	$6.81–$7.04	4

A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

The analysts at a glance

$94.50median target, 9% above the last close

Firms with a target · last 90 days: 6
Lowest – highest target: $80.00 – $99.00
Current grades of 12 firms: positive / neutral / negative: 0 / 8 / 4
Upgrades / downgrades · 12 months: 0 / 2
Consensus revenue growth · next 3 FY: +3% a year

Current grades

each firm's latest · 12 firms

As of	Firm	Grade
2026-10-15	Morgan Stanley	“Equal Weight”
2026-10-14	Citigroup	“Neutral”
2026-10-13	TD Cowen	“Hold”
2026-10-05	Wells Fargo	“Equal Weight”
2026-08-04	Evercore ISI	“Underperform”
2026-08-04	UBS	“Neutral”
2026-08-04	J.P. Morgan	“Underweight”
2026-07-28	Jefferies	“Hold”
2026-07-21	Barclays	“Underweight”
2026-07-20	BNP Paribas Exane	“Neutral”
2026-03-30	Deutsche Bank	“Hold”
2026-01-07	Goldman Sachs	“Sell”

Grade changes

last 24 months · 4

Date	Firm	Grade
2026-07-28	Jefferies	“Buy” → “Hold” downgrade
2026-04-17	J.P. Morgan	“Neutral” → “Underweight” downgrade
2025-01-07	Wells Fargo	“Underweight” → “Equal Weight” upgrade
2024-11-06	TD Cowen	“Sell” → “Hold” upgrade

54 older than 24 months

2024-10-01	Jefferies	“Hold” → “Buy” upgrade
2024-04-02	Citigroup	“Buy” → “Neutral” downgrade
2024-03-26	Jefferies	“Underperform” → “Hold” upgrade
2024-02-05	D.A. Davidson	“Buy” → “Neutral” downgrade
2023-12-15	Bank of America	“Underperform” → “Neutral” upgrade
2023-11-22	J.P. Morgan	“Underweight” → “Neutral” upgrade
2023-11-06	UBS	“Sell” → “Neutral” upgrade
2023-11-02	Citigroup	“Neutral” → “Buy” upgrade
2023-10-12	Bernstein	“Underperform” → “Market Perform” upgrade
2023-10-05	Raymond James	“Outperform” → “Market Perform” downgrade
2023-10-02	D.A. Davidson	“Neutral” → “Buy” upgrade
2023-08-03	Atlantic Equities	“Underweight” → “Neutral” upgrade
2022-10-17	Morgan Stanley	“Underweight” → “Equal Weight” upgrade
2022-02-04	Atlantic Equities	“Neutral” → “Underweight” downgrade
2022-02-02	Bernstein	“Market Perform” → “Underperform” downgrade
2022-01-26	Credit Suisse	“Neutral” → “Underperform” downgrade
2021-11-02	J.P. Morgan	“Neutral” → “Underweight” downgrade
2021-09-03	Argus Research	“Buy” → “Hold” downgrade
2021-08-04	Atlantic Equities	“Overweight” → “Neutral” downgrade
2021-05-03	Wells Fargo	“Equal Weight” → “Underweight” downgrade
2021-03-18	D.A. Davidson	“Buy” → “Neutral” downgrade
2021-02-19	Atlantic Equities	“Neutral” → “Overweight” upgrade
2020-12-14	Citigroup	“Neutral” → “Buy” upgrade
2020-10-16	J.P. Morgan	“Overweight” → “Neutral” downgrade
2020-03-19	Credit Suisse	“Outperform” → “Neutral” downgrade
2020-03-09	Argus Research	“Hold” → “Buy” upgrade
2020-03-04	CFRA	“Sell” → “Hold” upgrade
2020-02-04	CFRA	“Hold” → “Sell” downgrade
2019-09-23	Barclays	“Equal Weight” → “Underweight” downgrade
2019-05-20	Argus Research	“Buy” → “Hold” downgrade
2019-05-02	Deutsche Bank	“Sell” → “Hold” upgrade
2019-04-08	J.P. Morgan	“Neutral” → “Underweight” downgrade
2018-10-10	Deutsche Bank	“Hold” → “Sell” downgrade
2018-09-25	Argus Research	“Hold” → “Buy” upgrade
2018-07-18	Goldman Sachs	“Neutral” → “Sell” downgrade
2018-05-05	B. Riley	“Sell” → “Neutral” upgrade
2018-02-08	Argus Research	“Buy” → “Hold” downgrade
2017-01-09	Barclays	“Underweight” → “Equal Weight” upgrade
2016-12-16	Morgan Stanley	“Underweight” → “Equal Weight” upgrade
2016-09-16	Atlantic Equities	“Hold” → “Buy” upgrade
2016-02-26	Sterne Agee	“Buy” → “Neutral” downgrade
2016-02-26	Sterne Agee	“Buy” → “Neutral” downgrade
2015-01-15	Goldman Sachs	“Sell” → “Neutral” upgrade
2014-11-03	B. Riley	“Sell” → “Neutral” upgrade
2014-09-23	Citigroup	“Buy” → “Neutral” downgrade
2014-09-23	B. Riley	“Neutral” → “Sell” downgrade
2014-01-08	J.P. Morgan	“Neutral” → “Underweight” downgrade
2013-11-25	Goldman Sachs	“Neutral” → “Sell” downgrade
2013-10-17	Morgan Stanley	“Equal Weight” → “Underweight” downgrade
2013-09-20	Credit Suisse	“Neutral” → “Underperform” downgrade
2013-09-18	Barclays	“Equal Weight” → “Underweight” downgrade
2013-05-15	Credit Suisse	“Outperform” → “Neutral” downgrade
2013-03-18	Wellington Shields	“Hold” → “Buy” upgrade
2012-06-01	Citigroup	“Neutral” → “Buy” upgrade

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.